Scleritis
Welcome,         Profile    Billing    Logout  
 14 Companies   9 Products   9 Products   15 Mechanisms of Action   3 Trials   1201 News 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Scleritis
2017-004969-27: A multicenter randomized open-label trial comparing the efficacy and safety of Infliximab versus Cyclophosphamide in Subjects with Idiopathic Refractory Scleritis CIRIS: Cyclophosphamide vs. Infliximab for Refractory Idiopathic Scleritis Etude multicentrique randomisée en ouvert, comparant l'efficacité et la sécurité de l'infliximab versus le cyclophosphamide chez les sujets atteints de sclérite idiopathique réfractaire.(CIRIS: Cyclophosphamide vs Infliximab for Refractory Idiopathic Scleritis)

Not yet recruiting
3
53
Europe
Powder for concentrate for dispersion for infusion, Lyophilisate for solution for injection, Film-coated tablet, Inflectra, Endoxan, NOVATREX
Hospices Civils de Lyon, Ministère de la Santé
anterior idiopathic scleritis or anterior and posterior idiopathic scleritis sclérite antérieure idiopathique ou antérieure et postérieure, anterior idiopathic scleritis or anterior and posterior idiopathic scleritis sclérite antérieure idiopathique ou antérieure et postérieure, Diseases [C] - Eye Diseases [C11]
 
 
NCT03580343: Tofacitinib for Inflammatory Eye Disease

Active, not recruiting
2
5
US
tofacitinib, TOFA
Washington University School of Medicine
Uveitis, Scleritis
12/19
04/21
ATLAS , NCT03465111: A Clinical Study to Evaluate the Potential Role of ACTH Gel in Patients With Scleritis

Recruiting
2
30
US
ACTH (adrenocorticotropic hormone) gel, H.P. Acthar® Gel
Metropolitan Eye Research & Surgery Institute, Mallinckrodt, Stanford University, Ocular Imaging Research and Reading Center, Foresight Studies, LLC
Scleritis
12/24
12/24
NCT02656381: Uveitis/Intraocular Inflammatory Disease Biobank (iBank)

Completed
N/A
343
US
National Eye Institute (NEI)
Uveitis
05/23
05/23
AIDA, NCT05200715: AutoInflammatory Disease Alliance Registry

Recruiting
N/A
3500
Europe, US, RoW
No intervention is foreseen by the protocol.
University of Siena
Hereditary Autoinflammatory Diseases, Schnitzler Syndrome, Behcet Syndrome, PFAPA Syndrome, Still Disease, Autoinflammatory Syndrome, Unspecified, Uveitis, Scleritis, Vexas Syndrome
08/23
08/30

Download Options